Rachel Golonka1, Beng San Yeoh2, Matam Vijay-Kumar1,3. 1. Department of Physiology & Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614, USA. 2. Graduate Program in Immunology & Infectious Disease, Pennsylvania State University, University Park, PA 16802, USA. 3. Department of Medical Microbiology & Immunology, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614, USA.
Abstract
PURPOSE OF REVIEW: The supplementation of dietary additives into processed foods has exponentially increased in the past few decades. Similarly, the incidence rates of various diseases, including metabolic syndrome, gut dysbiosis and hepatocarcinogenesis, have been elevating. Current research reveals that there is a positive association between food additives and these pathophysiological diseases. This review highlights the research published within the past 5 years that elucidate and update the effects of dietary supplements on liver and intestinal health. RECENT FINDINGS: Some of the key findings include: enterocyte dysfunction of fructose clearance causes non-alcoholic fatty liver disease (NAFLD); non-caloric sweeteners are hepatotoxic; dietary emulsifiers instigate gut dysbiosis and hepatocarcinogenesis; and certain prebiotics can induce cholestatic hepatocellular carcinoma (HCC) in gut dysbiotic mice. Overall, multiple reports suggest that the administration of purified, dietary supplements could cause functional damage to both the liver and gut. SUMMARY: The extraction of bioactive components from natural resources was considered a brilliant method to modulate human health. However, current research highlights that such purified components may negatively affect individuals with microbiotal dysbiosis, resulting in a deeper break of the symbiotic relationship between the host and gut microbiota, which can lead to repercussions on gut and liver health. Therefore, ingestion of these dietary additives should not go without some caution!
PURPOSE OF REVIEW: The supplementation of dietary additives into processed foods has exponentially increased in the past few decades. Similarly, the incidence rates of various diseases, including metabolic syndrome, gut dysbiosis and hepatocarcinogenesis, have been elevating. Current research reveals that there is a positive association between food additives and these pathophysiological diseases. This review highlights the research published within the past 5 years that elucidate and update the effects of dietary supplements on liver and intestinal health. RECENT FINDINGS: Some of the key findings include: enterocyte dysfunction of fructose clearance causes non-alcoholic fatty liver disease (NAFLD); non-caloric sweeteners are hepatotoxic; dietary emulsifiers instigate gut dysbiosis and hepatocarcinogenesis; and certain prebiotics can induce cholestatic hepatocellular carcinoma (HCC) in gut dysbiotic mice. Overall, multiple reports suggest that the administration of purified, dietary supplements could cause functional damage to both the liver and gut. SUMMARY: The extraction of bioactive components from natural resources was considered a brilliant method to modulate human health. However, current research highlights that such purified components may negatively affect individuals with microbiotal dysbiosis, resulting in a deeper break of the symbiotic relationship between the host and gut microbiota, which can lead to repercussions on gut and liver health. Therefore, ingestion of these dietary additives should not go without some caution!
Entities:
Keywords:
Artificial Sweeteners; Emulsifiers; Gut Microbiome; Hepatocellular Carcinoma; High Fructose Corn Syrup; Probiotics and Prebiotics
Authors: Yanan Wang; Scott V Harding; Sijo J Thandapilly; Susan M Tosh; Peter J H Jones; Nancy P Ames Journal: Br J Nutr Date: 2017-11-08 Impact factor: 3.718
Authors: Luis Aldámiz-Echevarría; Javier de Las Heras; María Luz Couce; Carlos Alcalde; Isidro Vitoria; María Bueno; Javier Blasco-Alonso; María Concepción García; Mónica Ruiz; Rafael Suárez; Fernando Andrade; Olatz Villate Journal: Clin Nutr Date: 2019-02-15 Impact factor: 7.324
Authors: Zatollah Asemi; Mohammad Hossein Aarabi; Mohammad Hajijafari; Sabihe-Alsadat Alizadeh; Reza Razzaghi; Majid Mazoochi; Ahmad Esmaillzadeh Journal: Int J Prev Med Date: 2017-06-01
Authors: I Jane Cox; Abil E Aliev; Mary Me Crossey; Mahvish Dawood; Mamun Al-Mahtab; Sheikh M Akbar; Salimur Rahman; Antonio Riva; Roger Williams; Simon D Taylor-Robinson Journal: World J Gastroenterol Date: 2016-04-28 Impact factor: 5.742
Authors: Jadwiga Konieczna; Miguel Fiol; Antoni Colom; Miguel Ángel Martínez-González; Jordi Salas-Salvadó; Dolores Corella; María Trinidad Soria-Florido; J Alfredo Martínez; Ángel M Alonso-Gómez; Julia Wärnberg; Jesús Vioque; José López-Miranda; Ramon Estruch; M Rosa Bernal-López; José Lapetra; Lluís Serra-Majem; Aurora Bueno-Cavanillas; Josep A Tur; Vicente Martín Sánchez; Xavier Pintó; José J Gaforio; Pilar Matía-Martín; Josep Vidal; Clotilde Vázquez; Lidia Daimiel; Emilio Ros; Maira Bes-Rastrollo; María Pascual; Jose V Sorlí; Albert Goday; María Ángeles Zulet; Anai Moreno-Rodriguez; Francisco Jesús Carmona González; Rafael Valls-Enguix; Juana M Janer; Antonio Garcia-Rios; Rosa Casas; Ana M Gomez-Perez; José Manuel Santos-Lozano; F Javier Basterra-Gortari; María Ángeles Martínez; Carolina Ortega-Azorin; Joan Bayó; Itziar Abete; Itziar Salaverria-Lete; Miguel Ruiz-Canela; Nancy Babio; Lourdes Carres; Dora Romaguera Journal: Nutrients Date: 2022-10-05 Impact factor: 6.706